Bone density recovers quickly after stopping PrEP
Tenofovir treatment raises the risk of broken bones
People taking a large number of non-HIV-related medications more likely to stop or change HIV drugs
D:A:D study: long-term treatment with tenofovir associated with increased risk of serious liver disease
Ipergay PrEP study results published
Priorities for HIV care: the perspectives of healthcare providers and patients
Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved
